0001567619-22-017170.txt : 20220908
0001567619-22-017170.hdr.sgml : 20220908
20220908161037
ACCESSION NUMBER: 0001567619-22-017170
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220906
FILED AS OF DATE: 20220908
DATE AS OF CHANGE: 20220908
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Troendle August J.
CENTRAL INDEX KEY: 0001622058
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37856
FILM NUMBER: 221233933
MAIL ADDRESS:
STREET 1: 5375 MEDPACE WAY
CITY: CINCINNATI
STATE: OH
ZIP: 45227
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Medpace Holdings, Inc.
CENTRAL INDEX KEY: 0001668397
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 320434904
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5375 MEDPACE WAY
CITY: CINCINNATI
STATE: OH
ZIP: 45227
BUSINESS PHONE: (513) 579-9911
MAIL ADDRESS:
STREET 1: 5375 MEDPACE WAY
CITY: CINCINNATI
STATE: OH
ZIP: 45227
4
1
doc1.xml
FORM 4
X0306
4
2022-09-06
0
0001668397
Medpace Holdings, Inc.
MEDP
0001622058
Troendle August J.
C/O MEDPACE HOLDINGS, INC.
5375 MEDPACE WAY
CINCINNATI
OH
45227
1
1
1
0
CEO
Common Stock
2022-09-06
4
P
0
56557
147.59
A
5660986
I
By Medpace Investors, LLC
Common Stock
2022-09-07
4
P
0
56557
150.72
A
5717543
I
By Medpace Investors, LLC
Common Stock
806643
D
The purchases reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Medpace Investors, LLC ("MPI") on March 17, 2022, as amended on May 3, 2022 and August 15, 2022.
The reported price is a weighted average price. These shares were purchased in multiple transactions ranging from $144.76 to $149.51. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.
The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
The reported price is a weighted average price. These shares were purchased in multiple transactions ranging from $145.30 to $154.52. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.
/s/ Stephen P. Ewald, Attorney-in-Fact for August J. Troendle
2022-09-08